Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

957
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
957
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

611
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
611
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

743
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial Fibrillation.

JACC. Advances·2026
Same author

Correction: Estimating the Hawthorne Effect in Real-World Blood Pressure Control Trials: An Analysis of the BP Home Trial.

Journal of general internal medicine·2026
Same author

Predictors of ischemic stroke and major bleeding among patients with atrial fibrillation in clinical practice.

American heart journal·2026
Same author

Implementation of a single session psychotherapy intervention in primary care integrated behavioral health: a single-arm pilot study.

BMC primary care·2026
Same author

Population Estimates and Hypertension and Diabetes Prevalence: Cross-Sectional Quantitative Study Comparing Electronic Health Record-Derived Counts, Census, and Centers for Disease Control and Prevention Population Level Analysis and Community Estimates.

JMIR public health and surveillance·2026
Same author

Trends in Blood Pressure Control During the COVID-19 Pandemic: A Study of 17 US Health Systems in the National Patient-Centered Clinical Research Network Blood Pressure Control Laboratory.

Journal of the American Heart Association·2026

Related Experiment Videos

Multimorbidity in heart failure: a community perspective.

Alanna M Chamberlain1, Jennifer L St Sauver2, Yariv Gerber3

  • 1Department of Health Sciences Research, Mayo Clinic, Rochester, Minn.

The American Journal of Medicine
|September 16, 2014
PubMed
Summary

Heart failure patients frequently have multiple chronic conditions, with prevalence varying by heart failure type and sex. Understanding these comorbidities is crucial for effective patient management and improved outcomes.

Keywords:
ComorbidityHeart failureMultimorbidity

Related Experiment Videos

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Comorbidities significantly impact heart failure prognosis, increasing healthcare use and mortality.
  • The epidemiological patterns of comorbidities in heart failure, particularly by heart failure type and sex, require further investigation.

Purpose of the Study:

  • To investigate the prevalence and patterns of multimorbidity in patients with first-ever heart failure.
  • To examine differences in comorbidity occurrence based on heart failure type (preserved vs. reduced ejection fraction) and sex.

Main Methods:

  • Analysis of 16 chronic conditions in 1382 heart failure patients diagnosed between 2000-2010 in Olmsted County, MN.
  • Utilized heat maps to visualize pairwise comorbidity prevalences and observed-to-expected ratios stratified by heart failure type and sex.

Main Results:

  • 86% of heart failure patients had at least two additional chronic conditions; hypertension, hyperlipidemia, and arrhythmias were most common.
  • Men exhibited higher co-occurrence of cardiovascular diseases than women. Patients with preserved ejection fraction had more comorbidities (mean 4.5) than those with reduced ejection fraction (mean 3.7).
  • While overall patterns were similar, significant differences in co-occurrence ratios were observed by heart failure type and sex. Psychological and neurological conditions also showed higher-than-expected co-occurrence.

Conclusions:

  • Multimorbidity is highly prevalent in heart failure patients.
  • Distinct patterns of comorbidity co-occurrence exist between heart failure types and sexes.
  • Further research is needed to understand the clinical implications of these complex comorbidity profiles in heart failure management.